{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:20:33Z","timestamp":1791822033395,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jhepr.2024.101312","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T08:24:48Z","timestamp":1736324688000},"page":"101312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Quality of life in patients with HBV infection: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-7917","authenticated-orcid":false,"given":"Michael X.","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2778-0695","authenticated-orcid":false,"given":"Amelia","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibril","family":"Ndow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-3137","authenticated-orcid":false,"given":"Yazan","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Harvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sicuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-3380","authenticated-orcid":false,"given":"Shevanthi","family":"Nayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101312_bib1","series-title":"Global hepatitis report 2017","year":"2017"},{"key":"10.1016\/j.jhepr.2024.101312_bib2","series-title":"2024: monitoring health for the SDGs, sustainable development goals","year":"2024"},{"key":"10.1016\/j.jhepr.2024.101312_bib3","series-title":"Care and treatment for people with chronic hepatitis B infection","year":"2024"},{"key":"10.1016\/j.jhepr.2024.101312_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","author":"Razavi-Shearer","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib5","article-title":"Quality of life among people living with HIV in England and The Netherlands: a population-based study","volume":"8","author":"Popping","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jhepr.2024.101312_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37590","article-title":"Natural history and prognosis of hepatitis B","volume":"23","author":"Fattovich","year":"2003","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2024.101312_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/PROM.S226936","article-title":"Impact of stigma on people living with chronic hepatitis B","volume":"11","author":"Smith-Palmer","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.jhepr.2024.101312_bib8","first-page":"296","article-title":"Quality of life and hepatocellular carcinoma","volume":"5","author":"Gandhi","year":"2014","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"9 Suppl","key":"10.1016\/j.jhepr.2024.101312_bib9","first-page":"II151","article-title":"A\u00a0utility approach to the assessment of health-related quality of life","volume":"38","author":"Feeny","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.jhepr.2024.101312_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jhepr.2024.101312_bib11","series-title":"NICE DSU technical support document 9: the identification, review and synthesis of health state utility values from the literature","author":"Papaioannou","year":"2010"},{"key":"10.1016\/j.jhepr.2024.101312_bib12","first-page":"19.69","article-title":"The INTRABEAM\u00ae Photon Radiotherapy System for the Adjuvant Treatment of Early Breast Cancer: a systematic review and economic evaluation: critical appraisal checklist for health-related quality-of-life studies","volume":"2015","author":"Picot","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jhepr.2024.101312_bib13","series-title":"Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)","year":"2021"},{"key":"10.1016\/j.jhepr.2024.101312_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jval.2019.07.005","article-title":"A\u00a0systematic review and meta-analysis of health utilities in patients with chronic hepatitis C","volume":"23","author":"Saeed","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib15","article-title":"Normalization: a preprocessing stage","author":"Gopal","year":"2015","journal-title":"arXiv"},{"key":"10.1016\/j.jhepr.2024.101312_bib16","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jhepr.2024.101312_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5530\/jyp.2019.11.73","article-title":"Unani formulation improved quality of life in Indian Patients of chronic hepatitis B","volume":"11","author":"Ansari","year":"2019","journal-title":"J Young Pharmacistis"},{"key":"10.1016\/j.jhepr.2024.101312_bib18","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.7314\/APJCP.2014.15.12.4765","article-title":"Dynamics and liver disease specific aspects of quality of life among patients with chronic liver disease in Yunnan, China","volume":"15","author":"Che","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jhepr.2024.101312_bib19","article-title":"Health-related quality of life and its influencing factors in patients with hepatitis B: a cross-sectional assessment in Southeastern China","volume":"2021","author":"Chen","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib20","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/liv.14647","article-title":"Health related quality of life in chronic liver diseases","volume":"40","author":"Cortesi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101312_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/lt.21376","article-title":"Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index","volume":"14","author":"Dan","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2024.101312_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jceh.2020.04.003","article-title":"Psychiatric morbidity, fatigue, stigma and quality of life of patients with hepatitis B infection","volume":"10","author":"Gupta","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib23","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s11136-014-0670-3","article-title":"Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B","volume":"23","author":"Jia","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhepr.2024.101312_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cgh.2011.09.031","article-title":"Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B","volume":"10","author":"Kim","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7525-7-52","article-title":"Health-related quality of life of Southern Chinese with chronic hepatitis B infection","volume":"7","author":"Lam","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jhepr.2024.101312_bib26","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3748\/wjg.15.3288","article-title":"Psychometrics of the chronic liver disease questionnaire for Southern Chinese patients with chronic hepatitis B virus infection","volume":"15","author":"Lam","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101312_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1524-4733.2007.00297.x","article-title":"The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons","volume":"11","author":"Levy","year":"2008","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.jhepr.2024.101312_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162763","article-title":"Development and application of the Chinese (Mainland) version of Chronic Liver Disease Questionnaire to assess the health-related quality of life (HRQoL) in patients with chronic hepatitis B","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhepr.2024.101312_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.22138","article-title":"Health-related quality of life in chronic hepatitis B patients","volume":"47","author":"Siew","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101312_bib30","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s11136-013-0403-z","article-title":"Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients","volume":"22","author":"Wong","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhepr.2024.101312_bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s12072-021-10240-4","article-title":"Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis","volume":"15","author":"Wu","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2024.101312_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/PPA.S127139","article-title":"Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment","volume":"11","author":"Xue","year":"2017","journal-title":"Patient Prefer Adher"},{"key":"10.1016\/j.jhepr.2024.101312_bib33","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cgh.2018.02.037","article-title":"Effects of treatment of chronic hepatitis B virus infection on patient-reported outcomes","volume":"16","author":"Younossi","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib34","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/liv.14171","article-title":"Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: the impact of hepatitis B and C viral replication","volume":"39","author":"Younossi","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2024.101312_bib35","article-title":"Assessing health-related quality of life and health utilities in patients with chronic hepatitis B-related diseases in China: a cross-sectional study","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2024.101312_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7525-12-101","article-title":"Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls","volume":"12","author":"Zhuang","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jhepr.2024.101312_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2012\/736452","article-title":"Health state utilities and quality of life in patients with hepatitis B","volume":"26","author":"Woo","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101312_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21470-3","article-title":"Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan","volume":"12","author":"Sugimori","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2024.101312_bib39","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2014.06.034","article-title":"Health related quality of life in people with advanced chronic liver disease","volume":"61","author":"Orr","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","article-title":"Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy","volume":"57","author":"Peng","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib42","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.08001","article-title":"Population norms for the EQ-5D-3L in China derived from the 2013 national health services survey","volume":"11","author":"Yao","year":"2021","journal-title":"J Glob Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jval.2010.10.029","article-title":"Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available","volume":"14","author":"Ara","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib44","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/MLR.0b013e3181791a9c","article-title":"Utilities should not be multiplied: evidence from the preference-based scores in the United States","volume":"46","author":"Fu","year":"2008","journal-title":"Med Care"},{"key":"10.1016\/j.jhepr.2024.101312_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens","volume":"41","author":"Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2024.101312_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12939-017-0637-4","article-title":"More than a virus: a qualitative study of the social implications of hepatitis B infection in China","volume":"16","author":"Wallace","year":"2017","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib47","first-page":"423","article-title":"The majority of hepatitis B carriers are not on regular surveillance in Singapore","volume":"45","author":"Wai","year":"2004","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jhepr.2024.101312_bib48","article-title":"Use of quality-of-life instruments for people living with HIV: a global systematic review and meta-analysis","volume":"25","author":"Zhang","year":"2022","journal-title":"J\u00a0Int AIDS Soc"},{"key":"10.1016\/j.jhepr.2024.101312_bib49","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference","volume":"78","author":"Ghany","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101312_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005842","article-title":"Hepatitis B virus infection as a neglected tropical disease","volume":"11","author":"O\u2019Hara","year":"2017","journal-title":"Plos Negl Trop Dis"},{"key":"10.1016\/j.jhepr.2024.101312_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","article-title":"Beyond viral suppression of HIV - the new quality of life frontier","volume":"14","author":"Lazarus","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jhepr.2024.101312_bib52","series-title":"National clinical guideline centre hepatitis B (chronic)","year":"2013"},{"key":"10.1016\/j.jhepr.2024.101312_bib53","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","article-title":"Hepatitis B infection in the general population of China: a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2024.101312_bib54","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","article-title":"Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines","volume":"21","author":"Kennedy-Martin","year":"2020","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jhepr.2024.101312_bib55","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1016\/S2214-109X(17)30367-4","article-title":"Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial","volume":"5","author":"Thomas","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jval.2016.02.005","article-title":"Performance and validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in clinical trials of patients with chronic hepatitis C","volume":"19","author":"Younossi","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jval.2012.07.003","article-title":"Mapping from disease-specific to generic health-related quality-of-life scales: a common factor model","volume":"16","author":"Lu","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jhepr.2024.101312_bib58","article-title":"The impact of living with chronic hepatitis B on quality of life: implications for clinical management","volume":"10","author":"Ibrahim","year":"2023","journal-title":"J Patient Exp"},{"key":"10.1016\/j.jhepr.2024.101312_bib59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2024.101312_bib60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.21692","article-title":"Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0","volume":"46","author":"Spiegel","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101312_bib61","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jvh.13451","article-title":"Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV","volume":"28","author":"Younossi","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2024.101312_bib62","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/healthcare9101247","article-title":"Analysis of reproduction number R0 of COVID-19 using current health expenditure as gross domestic product percentage (CHE\/GDP) across countries","volume":"9","author":"Oshinubi","year":"2021","journal-title":"Healthcare"},{"key":"10.1016\/j.jhepr.2024.101312_bib63","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","article-title":"Hepatocellular carcinoma: old friends and new tricks","volume":"52","author":"Kim","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhepr.2024.101312_bib64","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81070","article-title":"The forgotten people: hepatitis B virus (HBV) infection as a priority for the inclusion health agenda","volume":"12","author":"Martyn","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jhepr.2024.101312_bib65","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101312_bib66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101312_bib67","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924003161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924003161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:56:19Z","timestamp":1749196579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924003161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2589555924003161"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101312","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life in patients with HBV infection: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101312"}}